Blog

Lucia Masarova: Let’s tackle the inflammation in myelofibrosis! Era of combinational therapies is here

Photo of Lucia Masarova taken from LinkedIn

Nov 22, 2023, 02:47

Lucia Masarova: Let’s tackle the inflammation in myelofibrosis! Era of combinational therapies is here

Lucia Masarova, Assistant Professor of the Department of Leukemia at MD Anderson Cancer Center, shared a post by Simrit Parmar, Assistant Professor of Stem Cell Transplant and Cellular Therapy at MD Anderson Cancer Centre on LinkedIn:

“Exciting, innovative, promising! Let’s tackle the inflammation in myelofibrosis! The era of combinational therapies is here.”

Quoting Simrit Parmar’s post:

“CXCR4 enriched T-Regulatory Cells Preferentially Home to Bone Marrow and Decrease Inflammation
oral presentation by Meixian Huang at 65th Annual American Society of Hematology meeting on Saturday, December 9, 2023 at 4:30 PM.”

For details click here.
Source: Lucia Masarova/LinkedIn and Simrit Parmar/LinkedIn

American Society of Hematology cancer Cellular Therapy CXCR4 Leukemia Lucia Masarova MD Anderson Cancer Center Meixian Huang myelofibrosis OncoDaily Oncology Simrit Parmar Stem Cell Transplant

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer